Is agmatine a novel neurotransmitter in brain?
暂无分享,去创建一个
[1] A. Yates,et al. Stimulus-secretion coupling of arginine-induced insulin release: comparison between the cationic amino acid and its methyl ester. , 2000, Endocrine.
[2] D. Reis,et al. Characterization of Arginine Decarboxylase in Rat Brain and Liver , 2000, Journal of neurochemistry.
[3] R. Blantz,et al. An emerging role for agmatine. , 1999, Kidney international.
[4] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[5] G. Olmos,et al. Protection by imidazol(ine) drugs and agmatine of glutamate‐induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor , 1999, British journal of pharmacology.
[6] D. Reis,et al. Anti‐Proliferative and Anti‐Inflammatory Actions of Imidazoline Agents: Are Imidazoline Receptors Involved? , 1999, Annals of the New York Academy of Sciences.
[7] I. Musgrave,et al. Novel Targets and Techniques in Imidazoline Receptor Research a , 1999, Annals of the New York Academy of Sciences.
[8] C. A. Ramsden,et al. Imidazolines and Pancreatic Hormone Secretion a , 1999, Annals of the New York Academy of Sciences.
[9] D. Reis,et al. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. , 1999, The Journal of pharmacology and experimental therapeutics.
[10] M. P. Dillon,et al. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. , 1998, Trends in pharmacological sciences.
[11] D. Reis,et al. Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells , 1998, Neuroscience Letters.
[12] D. Reis,et al. Regional localization of agmatine in the rat brain: an immunocytochemical study , 1998, Brain Research.
[13] D. Reis,et al. Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. , 1998, The Biochemical journal.
[14] D. Reis,et al. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. , 1998, Journal of psychiatric research.
[15] D. Reis,et al. Uptake of Agmatine into Rat Brain Synaptosomes: Possible Role of Cation Channels , 1997, Journal of neurochemistry.
[16] İ. Uzbay,et al. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. , 1997, Life sciences.
[17] J. Piletz,et al. Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[18] D. Reis,et al. Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery , 1996, British journal of pharmacology.
[19] D. Reis,et al. Agmatinase Activity in Rat Brain: A Metabolic Pathway for the Degradation of Agmatine , 1996, Journal of neurochemistry.
[20] J. Rabey,et al. Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia , 1996, Neuroscience Letters.
[21] G. Wilcox,et al. A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation , 1996, PAIN®.
[22] D. Reis,et al. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. , 1996, The Biochemical journal.
[23] G. Bennett,et al. Molecular characterization of adiY, a regulatory gene which affects expression of the biodegradative acid-induced arginine decarboxylase gene (adiA) of Escherichia coli. , 1996, Microbiology.
[24] D. Reis,et al. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. , 1996, The Journal of pharmacology and experimental therapeutics.
[25] G. Pasternak,et al. Modulation of opioid analgesia by agmatine. , 1996, European journal of pharmacology.
[26] P. Insel,et al. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. , 1996, The Journal of clinical investigation.
[27] D. Reis,et al. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes , 1995, Neuroreport.
[28] S. Kalra,et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro , 1995, Neuroscience Letters.
[29] D. Reis,et al. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. , 1995, Life sciences.
[30] S. Klahr,et al. Partial cloning and characterization of an arginine decarboxylase in the kidney. , 1995, Kidney international.
[31] F. Tesson,et al. Localization of I2-Imidazoline Binding Sites on Monoamine Oxidases (*) , 1995, The Journal of Biological Chemistry.
[32] P. Ernsberger,et al. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. , 1995, The Journal of pharmacology and experimental therapeutics.
[33] D. Reis,et al. An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells , 1995, Neuroscience Letters.
[34] D. Ash,et al. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. , 1994, Archives of biochemistry and biophysics.
[35] D. Reis,et al. Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.
[36] R. Malmberg,et al. Arginine decarboxylase of oats is activated by enzymatic cleavage into two polypeptides. , 1994, The Journal of biological chemistry.
[37] F. Tesson,et al. L 5 ‐ IMIDAZOLINE‐GUANIDINIUM RECEPTIVE SITE (IGRS): MITOCHONDRIAL DISTRIBUTION AND REGULATION PROPERTIES , 1992, Fundamental & clinical pharmacology.
[38] G. Gilad,et al. Polyamine uptake, binding and release in rat brain. , 1991, European journal of pharmacology.
[39] N. Morgan,et al. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. , 1990, European journal of pharmacology.
[40] R. Loring. Agmatine acts as an antagonist of neuronal nicotinic receptors , 1990, British journal of pharmacology.
[41] W. Malaisse,et al. Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine. , 1989, Biochemical pharmacology.
[42] D. Alkon,et al. Autoradiographic measurement of tritiated agmatine as an indicator of physiologic activity inHermissenda visual and vestibular neurons , 1986, Journal of neurocytology.
[43] S. Boyle,et al. Purification and properties of agmatine ureohydrolyase, a putrescine biosynthetic enzyme in Escherichia coli , 1986, Journal of bacteriology.
[44] W. H. Wu,et al. Biosynthetic arginine decarboxylase from Escherichia coli. Purification and properties. , 1973, The Journal of biological chemistry.
[45] D. Reis,et al. Agmatine: a novel neurotransmitter? , 1998, Advances in pharmacology.
[46] D. Reis,et al. Imidazoline receptors and their endogenous ligands. , 1996, Annual review of pharmacology and toxicology.
[47] B. Pfeiffer,et al. Insulin-like partial effects of agmatine derivatives in adipocytes. , 1980, Hoppe-Seyler´s Zeitschrift für physiologische Chemie.